Sunshine Biopharma Inc (SBFM) stock price

Sunshine Biopharma Inc (SBFM) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $0.90 (+6.76%), Market cap $0.00B, 52-week low–high $0.28 ~ $2.20.

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hyper

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Sunshine Biopharma Inc are updated in real time on BlackAll Trade.

Sunshine Biopharma Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Sunshine Biopharma Inc (SBFM) stock price?

Sunshine Biopharma Inc trades at $0.90 (+6.76%). Real-time quotes and charts are available on BlackAll Trade.

What is the Sunshine Biopharma Inc (SBFM) market cap?

Sunshine Biopharma Inc has a market cap of about $0.00B.

What does Sunshine Biopharma Inc (SBFM) do?

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in t